Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net loss	$ (5,217)	$ (23,877)
Adjustments to reconcile net loss to net cash provided by operating activities
Depreciation and amortization expense	12,390	9,037
Stock-based compensation expense	30,800	25,046
Net change in unrealized interest on held to maturity securities	4,258	14
Change in fair value of sales-based earnout liability	(1,364)	927
Accretion of acquisition consideration payable	0	634
Inventory write-down	934	1,037
Changes in assets and liabilities:
Accounts receivable, net	(9,957)	10,095
Inventories	(10,500)	(6,953)
Prepaid expenses and other assets	(1,235)	451
Accounts payable	6,880	(2,673)
Accrued expenses and other liabilities	4,196	1,296
Net cash provided by operating activities	31,185	15,034
Cash flows from investing activities
Purchase of held to maturity securities	(113,580)	(124,454)
Proceeds from maturity of held to maturity securities	610,782	177,089
Purchase of property and equipment	(13,316)	(16,310)
Cash paid for intangibles	(207)	(132)
Net cash provided by investing activities	483,679	36,193
Cash flows from financing activities
Tax withholding paid on behalf of employees for net share settlement	(27,831)	(13,479)
Payments of Financing Costs	(1,350)	0
Payment of contingent consideration towards earnouts	(3,966)	(5,013)
Net cash used in financing activities	(33,147)	(18,492)
Net increase in cash and cash equivalents	481,717	32,735
Cash and cash equivalents
Beginning of period	16,759	6,106
End of period	498,476	38,841
Supplemental disclosure of cash flow information
Income taxes paid	34	83
Supplemental disclosure of noncash investing and financing activities
Liabilities recorded for property, plant and equipment, net	3,656	13,492
Accrued deferred financing costs	650	0
Right-of-use assets acquired under operating leases	$ 113	$ 405